At the Nigerian Institute of Medical Research (NIMR), biochemist Farouq Busari spearheaded the deployment of an integrated antigen-mapping framework that combines automated immunoinformatics with standardised molecular workflows.

The initiative was designed to overcome long-standing delays associated with manual antigen screening, a bottleneck that often slows vaccine-relevant target identification during high-transmission periods.

Under Busari’s technical coordination, the research unit transitioned from fragmented prediction cycles to a unified digital pipeline capable of completing large-scale antigen screening in approximately 24 hours. This represented a substantial improvement over conventional approaches, which typically require multiple days depending on laboratory capacity and data volume.

Rather than focusing solely on computational speed, the team emphasised methodological rigour. New data-handling standards were introduced alongside improved contamination control, harmonised amplification parameters, and reproducible documentation practices. These changes led to a measurable decline in unusable samples during peak diagnostic windows, strengthening the quality of datasets feeding downstream epitope modelling and structural analysis.

A key innovation of the program was the early integration of structural validation into antigen prioritisation. By applying predictive modelling before wet-lab experimentation, researchers were able to narrow candidate regions in silico, reducing unnecessary laboratory iterations and directing resources toward the most promising viral targets.

This approach is particularly important for Lassa fever, a disease marked by significant genetic variation across geographic regions. Automated screening allows researchers to detect evolving antigenic patterns across large genomic datasets, enabling proactive rather than reactive response strategies.

Busari described the effort as part of a broader shift in African biomedical research toward digitally enabled outbreak preparedness.

“Computational biology cannot sit apart from laboratory science,” he noted. “When both operate together, response systems become anticipatory. That is how we move from managing outbreaks to predicting them.”

As computational infrastructure continues to expand across regional research centres, initiatives like this highlight the growing role of integrated molecular and digital platforms in strengthening epidemic readiness and supporting long-term vaccine development efforts throughout West Africa.